May 9th 2025
Poor API quality may often lead to delays in production and a shortage of supply.
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Wuxi's Biologics Facility Receives Honorable Mention at ISPE Facility of the Year Awards 2014
October 20th 2014The WuXi AppTec bulk cell culture production facility, designed by Sartorius Stedim Biotech (SSB), received an honorable mention in the 2014 Facility of the Year Awards at the annual meeting of International Society for Pharmaceutical Engineering (ISPE) in Las Vegas last week.